AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-94
Results: 26-50/94

Authors: Libby, P Ganz, P Schoen, FJ Lee, RT
Citation: P. Libby et al., Vascular biology of the acute coronary syndromes, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 33-57

Authors: Aikawa, M Fukumoto, Y Rabkin, E Libby, P
Citation: M. Aikawa et al., Rabbit models of atherosclerosis, CONTEMP CAR, 2001, pp. 175-191

Authors: Libby, P Aikawa, M Schonbeck, U
Citation: P. Libby et al., Cholesterol and atherosclerosis, BBA-MOL C B, 1529(1-3), 2000, pp. 299-309

Authors: Schonbeck, U Mach, F Libby, P
Citation: U. Schonbeck et al., CD154 (CD40 ligand), INT J BIO C, 32(7), 2000, pp. 687-693

Authors: Bourcier, T Libby, P
Citation: T. Bourcier et P. Libby, HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells, ART THROM V, 20(2), 2000, pp. 556-562

Authors: Libby, P
Citation: P. Libby, Changing concepts of atherogenesis, J INTERN M, 247(3), 2000, pp. 349-358

Authors: Libby, P Aikawa, M Kinlay, S Selwyn, A Ganz, P
Citation: P. Libby et al., Lipid lowering improves endothelial functions, INT J CARD, 74, 2000, pp. S3-S10

Authors: Libby, P
Citation: P. Libby, Multiple mechanisms of thrombosis complicating atherosclerotic plaques, CLIN CARD, 23(11), 2000, pp. 3-7

Authors: Schonbeck, U Sukhova, GK Shimizu, K Mach, F Libby, P
Citation: U. Schonbeck et al., Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice, P NAS US, 97(13), 2000, pp. 7458-7463

Authors: Byrne, GI Skarlotos, SI Grunfeld, C Kalayoglu, MV Libby, P Saikku, P Summersgill, JT Wyrick, P
Citation: Gi. Byrne et al., Collaborative multidisciplinary workshop report: Interface of lipid metabolism, atherosclerosis, and Chlamydia infection, J INFEC DIS, 181, 2000, pp. S490-S491

Authors: Shimizu, K Schonbeck, U Mach, F Libby, P Mitchell, RN
Citation: K. Shimizu et al., Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis, J IMMUNOL, 165(6), 2000, pp. 3506-3518

Authors: Marx, N Mach, F Sauty, A Leung, JH Sarafi, MN Ransohoff, RM Libby, P Plutzky, J Luster, AD
Citation: N. Marx et al., Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells, J IMMUNOL, 164(12), 2000, pp. 6503-6508

Authors: Kol, A Lichtman, AH Finberg, RW Libby, P Kurt-Jones, EA
Citation: A. Kol et al., Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells, J IMMUNOL, 164(1), 2000, pp. 13-17

Authors: Young, JL Sukhova, GK Foster, D Kisiel, W Libby, P Schonbeck, U
Citation: Jl. Young et al., The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1 beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells, J EXP MED, 191(9), 2000, pp. 1535-1544

Authors: Lee, RT Libby, P
Citation: Rt. Lee et P. Libby, Matrix metalloproteinases: not-so-innocent bystanders in heart failure, J CLIN INV, 106(7), 2000, pp. 827-828

Authors: Ducharme, A Frantz, S Aikawa, M Rabkin, E Lindsey, M Rohde, LE Schoen, FJ Kelly, RA Werb, Z Libby, P Lee, RT
Citation: A. Ducharme et al., Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction, J CLIN INV, 106(1), 2000, pp. 55-62

Authors: Fabunmi, RP Moore, KJ Libby, P Freeman, MW
Citation: Rp. Fabunmi et al., Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice, ATHEROSCLER, 148(2), 2000, pp. 375-386

Authors: Libby, P Dzau, VJ
Citation: P. Libby et Vj. Dzau, In memoriam - Arthur Mu-En Lee, CIRCUL RES, 87(10), 2000, pp. 831-832

Authors: Abi-Younes, S Sauty, A Mach, F Sukhova, GK Libby, P Luster, AD
Citation: S. Abi-younes et al., The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques, CIRCUL RES, 86(2), 2000, pp. 131-138

Authors: Haley, KJ Lilly, CM Yang, JH Feng, YJ Kennedy, SP Turi, TG Thompson, JF Sukhova, GH Libby, P Lee, RT
Citation: Kj. Haley et al., Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis -Using genomic technology to identify a potential novel pathway of vascularinflammation, CIRCULATION, 102(18), 2000, pp. 2185-2189

Authors: Libby, P Lee, RT
Citation: P. Libby et Rt. Lee, Matrix matters, CIRCULATION, 102(16), 2000, pp. 1874-1876

Authors: Aikawa, M Voglic, SJ Sugiyama, S Rabkin, E Libby, P Taubman, MB Fallon, JT
Citation: M. Aikawa et al., Decreased apoptosis and tissue factor expression after lipid lowering - Response, CIRCULATION, 102(13), 2000, pp. E99-E99

Authors: Furukawa, Y Mandelbrot, DA Libby, P Sharpe, AH Mitchell, RN
Citation: Y. Furukawa et al., Association of B7-1 co-stimulation with the development of graft arterial disease - Studies using mice lacking B7-1, B7-2, or B7-1/B7-2, AM J PATH, 157(2), 2000, pp. 473-484

Authors: Melian, A Libby, P Porcelli, S Geng, YJ
Citation: A. Melian et al., CD1 expression and the nature of CD1-expressing cells in human atherosclerotic plaques - Author's reply, AM J PATH, 156(4), 2000, pp. 1477-1478

Authors: Schonbeck, U Mach, F Sukhova, GK Herman, M Graber, P Kehry, MR Libby, P
Citation: U. Schonbeck et al., CD40 ligation induces tissue factor expression in human vascular smooth muscle cells, AM J PATH, 156(1), 2000, pp. 7-14
Risultati: 1-25 | 26-50 | 51-75 | 76-94